Pmv Pharmaceuticals Inc (PMVP)

Feb 20, 2025

PMVP Stock Sees Surge of Approximately 2.86% in Last Five Days - Knox Daily

Feb 20, 2025

Feb 19, 2025

Catalio Capital Management Joins $15 Million Series A for Perceive Pharma - citybiz

Feb 19, 2025

Feb 14, 2025

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Sees Significant Drop in Short Interest - MarketBeat

Feb 14, 2025

Feb 12, 2025

PMV Pharmaceuticals Reports Third Quarter 2024 Financial Results - br.ADVFN.com

Feb 12, 2025

Feb 11, 2025

PMV Pharmaceuticals to Participate at Upcoming Investor Conferences - GlobeNewswire

Feb 11, 2025

Feb 11, 2025

PMVP's Top Executives Set to Reveal Latest Oncology Developments at Major Healthcare Conferences - StockTitan

Feb 11, 2025

Jan 28, 2025

US Penny Stocks To Watch In January 2025 - Simply Wall St

Jan 28, 2025

Jan 26, 2025

Assenagon Asset Management S.A. Reduces Stock Holdings in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World

Jan 26, 2025

Jan 26, 2025

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Shares Sold by Assenagon Asset Management S.A. - MarketBeat

Jan 26, 2025

Jan 25, 2025

Barclays PLC Trims Stock Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World

Jan 25, 2025

Jan 25, 2025

Barclays PLC Trims Stock Holdings in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - MarketBeat

Jan 25, 2025

Jan 22, 2025

PMV Pharmaceuticals stock hits 52-week low at $1.32 By Investing.com - Investing.com Canada

Jan 22, 2025

Jan 21, 2025

PMV Pharmaceuticals stock hits 52-week low at $1.32 - MSN

Jan 21, 2025

Jan 15, 2025

Jane Street Group LLC Sells 89,957 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World

Jan 15, 2025

Jan 15, 2025

Jane Street Group LLC Sells 18,128 Shares of New Found Gold Corp. (NYSE:NFGC) - Defense World

Jan 15, 2025

Jan 13, 2025

PMV Pharmaceuticals stock hits 52-week low at $1.4 amid market challenges - Investing.com India

Jan 13, 2025

Jan 13, 2025

PMV Pharmaceuticals stock hits 52-week low at $1.4 amid market challenges By Investing.com - Investing.com South Africa

Jan 13, 2025

Jan 10, 2025

Barclays PLC Sells 434,704 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World

Jan 10, 2025

Jan 10, 2025

Barclays PLC Cuts Stock Holdings in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - MarketBeat

Jan 10, 2025

Jan 08, 2025

Kailera Therapeutics Appoints Laurie Stelzer as Chief Financial Officer - The Manila Times

Jan 08, 2025

Jan 07, 2025

PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials - GlobeNewswire

Jan 07, 2025

Jan 03, 2025

Layoff Tracker: Regeneron Acquisition of Oxular Wipes Out Oxular Workforce - BioSpace

Jan 03, 2025

Jan 02, 2025

Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech

Jan 02, 2025

Dec 30, 2024

PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial - Nature.com

Dec 30, 2024

Dec 20, 2024

Institutional investors may overlook Premier Investments Limited's (ASX:PMV) recent AU$278m market cap drop as long-term gains remain positive - Yahoo Finance

Dec 20, 2024

Dec 06, 2024

When Should You Buy Premier Investments Limited (ASX:PMV)? - Yahoo Finance

Dec 06, 2024

Dec 03, 2024

Discover 3 US Penny Stocks With Market Caps Over $40M - Simply Wall St

Dec 03, 2024

Dec 03, 2024

ArrowMark Colorado Holdings LLC Purchases 842,509 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - MarketBeat

Dec 03, 2024

Dec 03, 2024

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Given Average Rating of "Buy" by Brokerages - MarketBeat

Dec 03, 2024

Nov 29, 2024

Sio Capital Management LLC Boosts Stock Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - MarketBeat

Nov 29, 2024

Nov 28, 2024

PMVP (PMV Pharmaceuticals) 6-Month Price Index : 0.78 (As of Nov. 28, 2024) - GuruFocus.com

Nov 28, 2024

Nov 20, 2024

PMV Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer - MSN

Nov 20, 2024

Nov 18, 2024

Sionna Therapeutics Appoints Laurie Stelzer to its Board of Directors - citybiz

Nov 18, 2024

Nov 14, 2024

ArrowMark Colorado Holdings LLC Expands Stake in PMV Pharmaceuti - GuruFocus.com

Nov 14, 2024

Nov 12, 2024

BML Capital Management LLC Grows Stock Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - MarketBeat

Nov 12, 2024

Nov 11, 2024

Icahn Enterprises Releases Third Quarter 2024 Financial Results - Defense World

Nov 11, 2024

Nov 08, 2024

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Receives $5.80 Average Target Price from Brokerages - MarketBeat

Nov 08, 2024

Nov 08, 2024

PMV Pharmaceuticals (NASDAQ:PMVP) Upgraded at Oppenheimer - MarketBeat

Nov 08, 2024

Nov 08, 2024

Oppenheimer raises PMVP rating to Outperform, sets stock target on Q3 results - Investing.com UK

Nov 08, 2024

Nov 07, 2024

PMV Pharmaceuticals Inc (PMVP) Quarterly 10-Q Report - Quartz

Nov 07, 2024

Oct 31, 2024

Karyopharm stock gains as late-stage trial changes (KPTI:NASDAQ) - Seeking Alpha

Oct 31, 2024

Oct 28, 2024

Rezatapopt Monotherapy Remains Under Study Following Discontinuation of Combination Cohort in TP53+ Solid Tumors - OncLive

Oct 28, 2024

Oct 25, 2024

Dr Cristofanilli on Applications for Liquid Biopsy–Based MRD Testing in Breast Cancer - OncLive

Oct 25, 2024

Oct 24, 2024

CDC And Prevention Advisory Panel Backs Expanded Use Of Pfizer And Merck's Pneumococcal Vaccines - Yahoo Finance

Oct 24, 2024

Oct 23, 2024

US Penny Stocks To Consider In October 2024 - Simply Wall St

Oct 23, 2024

Oct 23, 2024

PMV Pharmaceuticals Provides a Progress Update on PYNNACLE Clinical Trial - GlobeNewswire

Oct 23, 2024

Oct 21, 2024

New Global Hematology Journal Strives to Feature Innovative and Adaptable Research - OncLive

Oct 21, 2024

Oct 17, 2024

Biodexa Pharmaceuticals (NASDAQ:BDRX) Stock Quotes, Forecast and News Summary - Benzinga

Oct 17, 2024